Patent · US Active

Composition for injection of hyaluronic acid, containing hyaluronic acid derivative and DNA fraction, and use thereof

US10456347B2 · kind B2 · utility

1Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2016
Grant dateOct 29, 2019
Priority date
Expiry dateNov 24, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08J2305/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.